5.4. summary evidence recommendations: management. 5.4.1. management primary prostate pain syndrome summary evidencelephenotypically directed treatment may improve treatment success.3α-blockers moderate treatment effect regarding total pain, voiding, qol scores ppps.1aantimicrobial therapy moderate effect total pain, voiding, qol scores ppps.1anon-steroidal anti-inflammatory drugs moderate overall treatment effects ppps.1aphytotherapy beneficial effect pain overall favourable treatment response ppps.1apentosane polysulphate improves global assessment qol score ppps.1bthere insufficient data effectiveness muscle relaxants ppps.2bpregabalin effective treatment ppps.1bbotulinum toxin type injection pelvic floor (or prostate) may modest effect ppps.2bacupuncture superior sham acupuncture improving symptoms qol.1aposterior tibial nerve stimulation probably effective treatment ppps.1bextracorporeal shock wave therapy probably effective short term.1bthere insufficient data supporting use surgical treatments, transurethral incision bladder neck, transurethral resection prostate, radical prostatectomy patients ppps.3cognitive behavioural therapy designed ppps may improve pain qol.3 recommendationsstrength ratingoffer multimodal phenotypically directed treatment options primary prostate pain syndrome (ppps).weakuse antimicrobial therapy (quinolones tetracyclines) minimum six weeks treatment-naïve patients duration ppps less one year.stronguse α-blockers patients duration ppps less one year.strongoffer high-dose oral pentosane polysulphate ppps.weakoffer acupuncture ppps.strongoffer non-steroidal anti-inflammatory drugs ppps, long-term side-effects considered.weak 5.4.2. management primary bladder pain syndrome summary evidencelethere insufficient data long-term use corticosteroids.3limited data exist effectiveness cimetidine pbps.2bamitriptyline effective pain related symptoms pbps.1boral pentosane polysulphate effective pain related symptoms pbps.1aoral pentosane polysulphate plus subcutaneous heparin effective pain related symptoms pbps, especially initially low responders pentosane polysulphate alone.1bintravesical lidocaine plus sodium bicarbonate effective short term.1bintravesical pentosane polysulphate effective, based limited data, may enhance oral treatment.1bthere limited data effectiveness intravesical heparin.3intravesical chondroitin sulphate may effective.2bthere insufficient data use bladder distension therapeutic intervention.3hydrodistension plus btx-a superior hydrodistension alone.1bintravesical bcg effective pbps.1btransurethral resection (coagulation laser) may effective pbps type 3 c.3sacral neuromodulation may effective pbps.3pudendal nerve stimulation superior sacral neuromodulation treatment pbps.1bavoidance certain foods drink may reduce symptoms.3outcome cystectomy pbps variable.3 recommendationsstrength ratingoffer subtype phenotype-oriented therapy treatment primary bladder pain syndrome (pbps).strongalways consider offering multimodal behavioural, physical psychological techniques alongside oral invasive treatments pbps.strongoffer dietary advice.weakadminister amitriptyline treatment pbps.strongoffer oral pentosane polysulphate treatment pbps.strongoffer oral pentosane polysulphate plus subcutaneous heparin low responders pentosane polysulphate alone.weakdo recommend oral corticosteroids long-term treatment.strongoffer intravesical hyaluronic acid chondroitin sulphate invasive measures.weakoffer intravesical lidocaine plus sodium bicarbonate prior invasive methods.weakoffer intravesical heparin invasive measures alone combination treatment.weakdo use bladder distension alone treatment pbps.weakconsider submucosal bladder wall trigonal injection botulinum toxin type plus hydrodistension intravesical instillation therapies failed.strongoffer neuromodulation invasive interventions.weakonly undertake ablative and/or reconstructive surgery last resort experienced pbps-knowledgeable surgeons, following multi-disciplinary assessment including pain management.strongoffer transurethral resection (or coagulation laser) bladder lesions, pbps type 3 c only.strong 5.4.3. management scrotal pain syndrome summary evidencelemicrosurgical denervation spermatic cord effective therapy primary scrotal pain syndrome.2bvasovasostomy effective post-vasectomy pain.2b recommendationsstrength ratinginform risk post-vasectomy pain counselling patients planned vasectomy.strongdo open instead laparoscopic inguinal hernia repair, reduce risk scrotal pain.strongin patients testicular pain improving spermatic block, offer microsurgical denervation spermatic cord.weak 5.4.4. management primary urethral pain syndrome summary evidencelethere specific treatment primary urethral pain syndrome.4 5.4.5. management gynaecological aspects chronic pelvic pain summary evidenceletherapeutic options, including pharmacotherapy surgery, treat endometriosis effectively.1bpsychological treatment (cbt supportive psychotherapy) improve pain sexual emotional function vaginal vulvar pain syndrome.1bmost gynaecological pain conditions (including dysmenorrhea, post-mesh insertion gynaecological malignancy) treated effectively using pharmacotherapy.3all gynaecological conditions (including obstetric injury, pelvic organ prolapse) treated effectively using surgery.2 recommendationsstrength ratinginvolve gynaecologist provide therapeutic options hormonal therapy surgery well-defined disease states.strongprovide multi-disciplinary approach pain management persistent disease states.strongall patients developed complications mesh insertion referred multi-disciplinary service (incorporating pain medicine surgery).strong 5.4.6. management primary anorectal pain syndrome summary evidencelebiofeedback preferred treatment chronic primary anal pain syndrome.1aelectro stimulation less effective biofeedback.1bavailable evidence fails confirm effectiveness btx-a management chronic primary anal pain syndrome.3percutaneous tibial nerve stimulation effective anal pain.3sacral neuromodulation effective anal pain.3inhaled salbutamol effective intermittent chronic primary anal pain syndrome.3 recommendationsstrength ratingundertake biofeedback treatment patients chronic anal pain.strongoffer percutaneous tibial nerve stimulation chronic primary anal pain syndrome.weakoffer sacral neuromodulation chronic primary anal pain syndrome.weakoffer inhaled salbutamol intermittent chronic primary anal pain syndrome.weak 5.4.7. management pudendal neuralgia summary evidencelethere multiple treatment options varying levels evidence.3 recommendationstrength ratingneuropathic pain guidelines well-established. use standard approaches management neuropathic pain.strong 5.4.8. management sexological aspects chronic pelvic pain summary evidencelepelvic floor muscle physical therapy may offer relief pain reduction sexual complaints.2b recommendationsstrength ratingoffer behavioural strategies patient his/her partner reduce sexual dysfunctions.weakoffer pelvic floor muscle therapy part treatment plan improve quality life sexual function.weak 5.4.9. management psychological aspects chronic pelvic pain recommendationstrength ratingfor chronic pelvic pain significant psychological distress, refer patient chronic pelvic pain-focused psychological treatment.strong 5.4.10. management pelvic floor dysfunction summary evidencelemyofascial treatment effective.1bbiofeedback improves outcome myofascial therapy.1a recommendationsstrength ratingapply myofascial treatment first-line treatment.weakoffer biofeedback therapy adjuvant muscle exercises, patients anal pain due overactive pelvic floor.strong 5.4.11. management chronic/non-acute urogenital pain opioids recommendationsstrength ratingopioids drugs addiction/dependency prescribed following multi-disciplinary assessment reasonable treatments tried failed.strongthe decision instigate long-term opioid therapy made appropriately trained specialist consultation patient family doctor.strongwhere history suspicion drug abuse, involve psychiatrist psychologist interest pain management drug addiction.strong